QV Investors Inc. lessened its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 55,230 shares of the healthcare conglomerate’s stock after selling 2,730 shares during the period. QV Investors Inc.’s holdings in UnitedHealth Group were worth $17,219,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in UNH. State Street Corp increased its holdings in UnitedHealth Group by 0.5% during the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after purchasing an additional 212,240 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its position in UnitedHealth Group by 22.6% during the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 484,187 shares of the healthcare conglomerate’s stock valued at $120,747,000 after acquiring an additional 89,211 shares in the last quarter. Silvercrest Asset Management Group LLC boosted its position in UnitedHealth Group by 7.8% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 10,135 shares of the healthcare conglomerate’s stock valued at $2,527,000 after acquiring an additional 734 shares in the last quarter. Driehaus Capital Management LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at approximately $209,000. Finally, Balyasny Asset Management LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at approximately $3,636,000. Institutional investors own 86.39% of the company’s stock.
Shares of NYSE UNH opened at $329.90 on Friday. UnitedHealth Group Inc has a twelve month low of $187.72 and a twelve month high of $333.70. The firm has a market cap of $313.52 billion, a P/E ratio of 18.55, a PEG ratio of 1.44 and a beta of 0.68. The company has a 50 day moving average of $311.35 and a 200 day moving average of $297.69. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, beating analysts’ consensus estimates of $2.98 by $0.53. The business had revenue of $65.12 billion during the quarter, compared to analyst estimates of $63.97 billion. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business earned $3.88 EPS. As a group, equities analysts expect that UnitedHealth Group Inc will post 16.58 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a dividend of $1.25 per share. The ex-dividend date was Friday, September 11th. This represents a $5.00 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
Several analysts have weighed in on UNH shares. Mizuho reaffirmed a “buy” rating and set a $315.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, July 15th. Bank of America lifted their price objective on UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a research report on Friday, August 28th. Morgan Stanley reaffirmed a “buy” rating and set a $371.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 16th. Raymond James lifted their price objective on UnitedHealth Group from $350.00 to $355.00 and gave the company a “strong-buy” rating in a research report on Thursday. Finally, Stephens boosted their price target on UnitedHealth Group from $325.00 to $335.00 and gave the stock an “overweight” rating in a research report on Thursday, July 16th. Four investment analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $346.68.
In other UnitedHealth Group news, EVP Marianne D. Short sold 12,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the completion of the sale, the executive vice president now directly owns 140,885 shares in the company, valued at approximately $45,271,985.90. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction on Wednesday, July 22nd. The stock was sold at an average price of $303.50, for a total value of $3,035,000.00. Following the completion of the sale, the director now owns 159,215 shares of the company’s stock, valued at $48,321,752.50. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,336 shares of company stock valued at $14,928,276. Company insiders own 0.80% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Technical Analysis
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.